Evidence map›Paper›PMID 29572554›Full record

ArticleScientific reports2018

MultiBacMam Bimolecular Fluorescence Complementation (BiFC) tool-kit identifies new small-molecule inhibitors of the CDK5-p25 protein-protein interaction (PPI).

Itxaso Bellón-Echeverría, Jean-Philippe Carralot, Andrea Araujo Del Rosario, Stephanie Kueng, Harald Mauser, Georg Schmid, Ralf Thoma, Imre Berger

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Itxaso Bellón-EcheverríaChemical Biology, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Jean-Philippe CarralotChemical Biology, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Andrea Araujo Del RosarioChemical Biology, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Stephanie KuengChemical Biology, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Harald MauserGlobal Technical Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Georg SchmidChemical Biology, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Ralf ThomaChemical Biology, pRED Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland. ralf.thoma@roche.com.
Imre BergerBrisSynBio Centre and School of Biochemistry, Bristol University, Clifton, BS8 1TD, United Kingdom. imre.berger@bristol.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/L01386X/1
6 · The paper itself

Abstract

Protein-protein interactions (PPIs) are at the core of virtually all biological processes in cells. Consequently, targeting PPIs is emerging at the forefront of drug discovery. Cellular assays which closely recapitulate native conditions in vivo are instrumental to understand how small molecule drugs can modulate such interactions. We have integrated MultiBacMam, a baculovirus-based mammalian gene delivery tool we developed, with bimolecular fluorescence complementation (BiFC), giving rise to a highly efficient system for assay development, identification and characterization of PPI modulators. We used our system to analyze compounds impacting on CDK5-p25 PPI, which is implicated in numerous diseases including Alzheimer's. We evaluated our tool-kit with the known inhibitor p5T, and we established a mini-screen to identify compounds that modulate this PPI in dose-response experiments. Finally, we discovered several compounds disrupting CDK5-p25 PPI, which had not been identified by other screening or structure-based methods before.

Indexed as

AnimalsCell LineChlorocebus aethiopsCOS CellsCyclin-Dependent Kinase 5Drug DiscoveryDrug Evaluation, PreclinicalFluorescenceHumansMolecular Docking SimulationNerve Tissue ProteinsProtein Interaction MapsSmall Molecule LibrariesCyclin-Dependent Kinase 5Nerve Tissue ProteinsSmall Molecule LibrariesTPPP protein, human

Identifiers

PMID29572554
PMCPMC5865166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.